Changes At Pew Charitable Trusts: Good News For Scientists?

Scientists have taken over at the Pew Charitable Trusts. A year and a half ago, Thomas Langfltt, a former University of Pennsylvania neurosurgeon assumed the presidency, replacing Robert I. Smith, whose background was in accounting. Now, Rebecca Rimel, a former nurse and medical school faculty member, has been promoted to the post of executive director. She succeeds Fred Billups, a former oil company executive who had filled Pew's second highest post for 12 years. Is this good news for scientist

Written byJim Detjen
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

The new leadership comes at a time of considerable change for the 40-year-old trusts. The first of the seven trusts was founded in 1948 by the descendants of Joseph N. Pew, founder of Sun Oil Co. During the last decade, the fund has been transformed from a wealthy but parochial organization with a reputation for giving away large grants to conservative groups, into a professionally managed foundation with a growing interest in national and international issues. Eight years ago it started a new pattern of giving: While in the past it was primarily a reactive body, passing judgment on proposals submitted to it, its board now aggressively earmarks multimillion-dollar allocations for specific purposes and then puts out calls for proposals in those areas.

Last year, the seven individual trusts that constitute the $2.3 billion Pew Charitable Trusts awarded 473 grants totaling $130.4 million. Twenty-nine percent of that money-109 grants totaling ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies